These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12410354)

  • 1. Primary hyperparathyroidism, C-cell hyperplasia and papillary thyroid carcinoma in a patient with RET germline polymorphism S836S.
    Brauckhoff M; Gimm O; Bilkenroth U; Hinze R; Dralle H
    Langenbecks Arch Surg; 2002 Oct; 387(5-6):201-3. PubMed ID: 12410354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline sequence variant S836S in the RET proto-oncogene is associated with low level predisposition to sporadic medullary thyroid carcinoma in the Spanish population.
    Ruiz A; Antiñolo G; Fernández RM; Eng C; Marcos I; Borrego S
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):399-402. PubMed ID: 11589684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillary thyroid carcinoma in patients with RET proto-oncogene germline mutation.
    Brauckhoff M; Gimm O; Hinze R; Ukkat J; Brauckhoff K; Dralle H
    Thyroid; 2002 Jul; 12(7):557-61. PubMed ID: 12193298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papillary thyroid carcinoma, parathyroid adenoma, and unexplained hypercalcitoninemia: an unusual presentation of multiple endocrine neoplasia type 2A?
    Rone JK; Lane AG; Grinkemeyer MD
    Thyroid; 1998 Sep; 8(9):781-5. PubMed ID: 9777749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients.
    Niccoli-Sire P; Murat A; Rohmer V; Franc S; Chabrier G; Baldet L; Maes B; Savagner F; Giraud S; Bezieau S; Kottler ML; Morange S; Conte-Devolx B;
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3746-53. PubMed ID: 11502806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of RET codon 691 polymorphism in radiation-induced human thyroid tumours with C-cell hyperplasia in peritumoural tissue.
    Bounacer A; Du Villard JA; Wicker R; Caillou B; Schlumberger M; Sarasin A; Suárez HG
    Br J Cancer; 2002 Jun; 86(12):1929-36. PubMed ID: 12085189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation.
    Gimm O; Neuberg DS; Marsh DJ; Dahia PL; Hoang-Vu C; Raue F; Hinze R; Dralle H; Eng C
    Oncogene; 1999 Feb; 18(6):1369-73. PubMed ID: 10022819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel germline RET mutation segregating with papillary thyroid carcinomas.
    Rey JM; Brouillet JP; Fonteneau-Allaire J; Boneu A; Bastié D; Maudelonde T; Pujol P
    Genes Chromosomes Cancer; 2001 Dec; 32(4):390-1. PubMed ID: 11746981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
    Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent lymph node metastases of medullary and papillary thyroid carcinoma in a case with RET oncogene germline mutation.
    Papi G; Corrado S; Pomponi MG; Carapezzi C; Cesinaro A; LiVolsi VA
    Endocr Pathol; 2003; 14(3):269-76. PubMed ID: 14586073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of medullary thyroid carcinoma, bronchial carcinoid tumor, and papillary thyroid carcinoma in a family bearing the RET G691S polymorphism.
    Rotondi M; Ercolino T; Fonte R; Lagonigro MS; Leporati P; Villani L; La Manna L; Mannelli M; Chiovato L
    J Endocrinol Invest; 2009 Feb; 32(2):115-8. PubMed ID: 19411807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical strategy in a kindred with a rare RET protooncogene mutation of variable penetrance with regard to multiple endocrine neoplasia.
    Colombo-Benkmann M; Brämswig J; Höppner W; Gellner R; Hengst K; Böcker W; Senninger N
    World J Surg; 2002 Oct; 26(10):1286-90. PubMed ID: 12205548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population.
    Elisei R; Cosci B; Romei C; Bottici V; Sculli M; Lari R; Barale R; Pacini F; Pinchera A
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3579-84. PubMed ID: 15240649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline RET 634 mutation positive MEN 2A-related C-cell hyperplasias have genetic features consistent with intraepithelial neoplasia.
    Diaz-Cano SJ; de Miguel M; Blanes A; Tashjian R; Wolfe HJ
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3948-57. PubMed ID: 11502837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin.
    Kaserer K; Scheuba C; Neuhold N; Weinhäusel A; Vierhapper H; Haas OA; Niederle B
    Am J Surg Pathol; 1998 Jun; 22(6):722-8. PubMed ID: 9630179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of risk of inherited medullary thyroid carcinoma in apparent sporadic patients.
    Wiench M; Wygoda Z; Gubala E; Wloch J; Lisowska K; Krassowski J; Scieglinska D; Fiszer-Kierzkowska A; Lange D; Kula D; Zeman M; Roskosz J; Kukulska A; Krawczyk Z; Jarzab B
    J Clin Oncol; 2001 Mar; 19(5):1374-80. PubMed ID: 11230481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The RET gene in thyroid pathology].
    Michiels FM; Billaud M
    Arch Anat Cytol Pathol; 1998; 46(1-2):19-30. PubMed ID: 9754357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas.
    Jhiang SM; Sagartz JE; Tong Q; Parker-Thornburg J; Capen CC; Cho JY; Xing S; Ledent C
    Endocrinology; 1996 Jan; 137(1):375-8. PubMed ID: 8536638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2.
    Pausova Z; Soliman E; Amizuka N; Janicic N; Konrad EM; Arnold A; Goltzman D; Hendy GN
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2711-8. PubMed ID: 8675600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.